Results 151 to 160 of about 157,713 (224)

Frailty determinants in heart failure: Inflammatory markers, cognitive impairment and psychosocial interaction

ESC Heart Failure, EarlyView.
Abstract Aims This study aimed to identify factors associated with frailty in heart failure (HF) patients, focusing on demographic, biochemical and health‐related variables. It also explored the correlation between frailty and comorbidities such as malnutrition, cognitive impairment and depression, assessing how these factors interact to influence ...
Marta Wleklik, Christopher S. Lee, Łukasz Lewandowski, Michał Czapla, Maria Jędrzejczyk, Heba Aldossary, Izabella Uchmanowicz   +6 more
wiley   +1 more source

Trends in pulmonary arterial hypertension: insights from Global Burden of Disease 1990-2021. [PDF]

BMJ Open
Wu X, Suo S, Su X, Sun L, Zheng Y, Wang Y, Liu H.   +6 more
europepmc   +1 more source

Investigation of Second Genetic Hits at the BMPR2 Locus as a Modulator of Disease Progression in Familial Pulmonary Arterial Hypertension [PDF]

, 2005
Rajiv D. Machado, Victoria James, Mark Southwood, Rachel E. Harrison, Carl Atkinson, Susan Stewart, Nicholas W. Morrell, Richard C. Trembath, Micheala A. Aldred   +8 more
openalex   +1 more source

Randomized trial to assess worsening renal function by adding dapagliflozin for acute decompensated heart failure

ESC Heart Failure, EarlyView.
Abstract Aims Dapagliflozin (DAPA), a sodium‐glucose co‐transporter 2 inhibitor, has been shown to reduce cardiovascular mortality among patients with chronic heart failure. We aimed to evaluate the impact on a worsening renal function (WRF) by adding DAPA as compared to standard decongestive therapy with loop diuretics alone.
Shodai Kawanami, Yasuyuki Egami, Masaru Abe, Mizuki Osuga, Hiroaki Nohara, Kohei Ukita, Akito Kawamura, Koji Yasumoto, Naotaka Okamoto, Yasuharu Matsunaga‐Lee, Masamichi Yano, Masami Nishino   +11 more
wiley   +1 more source

A Novel Missense Variant of <i>ZC3H12A</i> in Pulmonary Arterial Hypertension. [PDF]

Circ Rep
Asano R, Okazawa M, Ishibashi T, Ding X, Ohta-Ogo K, Akaki K, Umeki-Mizushima S, Yamagishi A, Inagaki T, Yaku A, Fujisaki S, Kiko T, Hatakeyama K, Takeuchi O, Ogo T, Nakaoka Y.   +15 more
europepmc   +1 more source

Soluble CD40 Ligand in Pulmonary Arterial Hypertension

, 2004
J Damås, Kari Otterdal, Arne Yndestad, Halfdan Aass, Nils Olav Solum, Stig S. Frøland, Svein Simonsen, Pål Aukrust, Arne K. Andreassen   +8 more
openalex   +1 more source

Thyroid function, pulmonary arterial hypertension and scleroderma [PDF]

, 2005
Bianca Marasini, Marco Massarotti, R. Cossutta   +2 more
openalex   +1 more source

Association between the Tpeak‐Tend interval on admission and coronary microvascular dysfunction in Takotsubo syndrome

ESC Heart Failure, EarlyView.
Abstract Aims The Tpeak‐Tend interval on electrocardiogram may be a predictor of worse outcomes in Takotsubo syndrome (TTS), but the mechanisms have not been fully determined. This study aimed to investigate the relationships between the corrected Tpeak‐Tend (cTp‐e) interval and coronary microvascular‐dysfunction (CMD) assessed by the angiography ...
Kyohei Onishi, Masafumi Ueno, Nobuhiro Yamada, Kazuyoshi Kakehi, Kosuke Fujita, Koichiro Matsumura, Gaku Nakazawa   +6 more
wiley   +1 more source

Pulmonary arterial hypertension in Latin America. The age and comorbidity paradox. [PDF]

Int J Cardiol Congenit Heart Dis
Pulido T, de la Cruz-Perez S, Valencia D, Conde R, Lescano A, Zayas N.   +5 more
europepmc   +1 more source

858-3 Subcutaneous treprostinil therapy evokes both survival benefit and continuous dose-dependent efficacy improvements in patients with pulmonary arterial hypertension: A long-term European multicentre analysis of 112 patients

, 2004
Iréne Lang, Miguel Ángel Gómez‐Sánchez, Meinhard Kneußl, Pilar Escribano Subías, Robert Naejie, Jean-Luc Vachiéry   +5 more
openalex   +1 more source